CONTROLLED TRIAL OF LOW-DOSE HEPARIN AND SULFINPYRAZONE TO PREVENT VENOUS THROMBOEMBOLISM AFTER OPERATION ON HIP

被引:57
作者
ROGERS, PH
WALSH, PN
MARDER, VJ
BOSAK, GC
LACHMAN, JW
RITCHIE, WGM
OPPENHEIMER, L
SHERRY, S
机构
关键词
D O I
10.2106/00004623-197860060-00005
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
引用
收藏
页码:758 / 762
页数:5
相关论文
共 27 条
[11]   PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT - WARFARIN VS DEXTRAN-40 [J].
HARRIS, WH ;
SALZMAN, EW ;
DESANCTIS, RW ;
COUTTS, RD .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 220 (10) :1319-+
[12]   ASPIRIN PROPHYLAXIS OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP-REPLACEMENT [J].
HARRIS, WH ;
SALZMAN, EW ;
ATHANASOULIS, CA ;
WALTMAN, AC ;
DESANCTIS, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (23) :1246-1249
[13]  
IVINS JC, 1967, SURG GYNECOL OBSTETR, V125, P1281
[14]  
JICK H, 1969, LANCET, V1, P539
[15]  
JOHNSON SR, 1968, ACTA CHIR SCAND S387, P80
[16]   RESULTS OF TREATMENT OF HIP DISORDERS WITH CUP ARTHROPLASTY [J].
JOHNSTON, RC ;
LARSON, CB .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1969, A 51 (08) :1461-+
[17]  
KAKKAR VV, 1972, LANCET, V2, P101
[18]  
KAKKAR VV, 1970, LANCET, V1, P540
[19]  
Merck KGaA, PRODUCT INFORMATION
[20]  
MORRIS GK, 1976, LANCET, V2, P867